As featured in a video from myCME.com, "Tom Sullivan (left) and Andy Rosenberg of the CME Coalition labored tirelessly to get CME activities to be considered Improvement Activities under MIPS. Here's what it means."
 This post was originally published as a November 16, 2017 article on MeetingsNet.
The Medicare Access and Chip Reauthorization Act of 2015, a congressional effort to solve the riddle of how to pay physicians under the Medicare program, does more than move what has traditionally been a fee-for-service model to a value-based model. It also just may offer some new areas of opportunities for continuing medical education. Andy Rosenberg, senior advisor with the lobbying group the CME Coalition, laid out just what MACRA is—and why CME providers should be paying attention to it—in a recent MeetingsNet webinar.
On Tuesday, myCME's David Azevedo caught up with Andy Rosenberg and Tom Sullivan of the CME Coalition to discuss the latest developments related to MACRA and CME . “I think there’s an openness in the government to make things easier for physicians to get credit for the work they are doing,” noted Sullivan in the interview. "If I’m going to participate in a quality improvement program, that should qualify as quality improvement.” Rosenberg went on to comment that he is “hopeful” now that CMS has opened up the process to reconsider new measures. “I’m very bullish on our long-term chances of eventually getting them to recognize a role for CME in MIPS," he said.
Policy and Medicine Highlights CME Coalition participation in FDA meeting on Safe Opioid Use5/26/2017
Policy and Medicine: Open Payments Having an Adverse Effect on Physician-Rep Relationships11/2/2016
 An article published in Policy and Medicine shows that since the release of Open Payments data, the percentage of physicians who do not allow access to medical industry salespeople have begun to increase. However, author Tom Sullivan argues that the increasing no-access rate might not be very beneficial for physicians. "Such high rates of no-access may not be the best thing for the health care industry as a whole" he writes. "Such visits from drug and device reps can be beneficial to doctors and their staff, as it provides a time for them to ask questions of the rep to see if the offered device or prescription is a good fit for any of their patients."
Inside Health Policy: Physician Groups Push Senate Bill Waiving CME From Sunshine Reporting7/19/2016
 Today, Inside Health Policy reported on a letter sent by the American Medial Association (AMA) and other medical groups urging passage of Sen. John Barrasso's (R-WY) legislation (S. 2978) that would exempt continuing medical education (CME) activities from Sunshine Act reporting requirements. As the article notes, a Centers for Medicare and Medicaid Services (CMS) interpretation of the Physician Payments Sunshine Act has deemed that medical textbooks, reprints of peer-reviewed scientific clinical journal articles, and abstracts of those articles are not directly beneficial to patients - and are therefore subject to reporting requirements. The physician groups note that the interpretation is "inconsistent with the reality of clinical practice" and that Sen. Barrasso's legislation would "ensure that efforts to promote transparency do not undermine efforts to provide the most up-to-date independent medical knowledge."
|
